Australian Investors Podcast cover image

Three ASX shares for exciting growth: ResMed, GenTrack & Pinnacle

Australian Investors Podcast

00:00

Investing in Sleep Health: ResMed and Beyond

This chapter explores three promising ASX companies, focusing on ResMed's advancements in sleep apnea treatment and digital care. The discussion connects GLP-1 drugs like Ozempic to sleep health trends, emphasizing the potential for future growth and the impact of wearable technology on treatment compliance.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app